Program to promote lung regeneration and block fibrosis
促进肺再生和阻止纤维化的计划
基本信息
- 批准号:9893639
- 负责人:
- 金额:$ 96.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-15 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AlveolarAnimal ModelAttenuatedAutomobile DrivingBiopsyCellsClinicClinical TrialsDataDiagnosticDiseaseEnvironmentEpigallocatechin GallateEpithelialEpitheliumFailureFibroblastsFibrosisFunctional disorderFundingFutureGoalsHealthHumanInjuryLOXL2 geneLungLung TransplantationLung diseasesMesenchymalMorbidity - disease rateMusNatural regenerationOrganoidsPathway interactionsPatientsProcessPulmonary FibrosisResearchTestingTimeTissuesType II Epithelial Receptor Cellbasecytokineepithelial injuryepithelium regenerationfibrogenesisimprovedin vivoinhibitor/antagonistlung regenerationmolecular imagingmortalitynovel therapeutic interventionprogenitorprogramssingle-cell RNA sequencingsmall moleculestemstem cellstissue biomarkers
项目摘要
ABSTRACT
The goal of this research program is to understand the interactions between lung epithelial and mesenchymal
cells in sufficient detail to deliver new therapeutic interventions in pulmonary fibrosis, a process without disease
modifying therapies. This program is anchored by a recently funded RO1 to further elucidate mechanisms of a
fibroblast-specific trihydroxyphenolic inhibitor of LOXL2 and TGFR1 with potent in vivo anti-fibrotic effects. We
will test one of these, EGCG, in a proof of principle clinical trial. Unpublished data show reversal of a core set
of pro-fibrotic tissue biomarkers in IPF patients given EGCG two weeks prior to diagnostic lung biopsy. The
R35 mechanism allows us to integrate our capacity to attenuate fibrosis with the broader issue of defective
epithelial regeneration in IPF, a competing process with fibrogenesis. This is sometimes simplified in the idea
repeated epithelial injury leads to stem cell failure thereby creating an unrelenting pro-fibrotic environment. But
the lung is resilient with multiple, spatially distinct progenitor cells whose identify and integrative functions
remain poorly understood, especially in IPF patients. This paradigm also overlooks the potentially critical
contribution of pro-fibrotic mesenchymal cells in driving further loss of the epithelium. Type II cells in the IPF
lung at the time of lung transplant are less than 15% of that present in a normal lung. The program will focus
on further elucidating the potential of resident epithelial stem/progenitors in mouse and human to regenerate
alveolar integrity. In parallel, mechanisms by which activated mesenchymal cells contribute to dysfunction and
loss of these epithelial progenitors will be defined. We plan to leverage fibroblast-specific TGFb1 inhibition to
study its impact on progenitor cells in both animal models and in IPF patients, for example by single cell RNA-
seq of tissues from untreated and EGCG treated patients. We envision a future small molecule image-based
screen to identify agents that improve type II cell health in cultured epithelial/fibroblast organoids. Overall the
R35 program gives us the opportunity to integrate all of these directions into a centrally themed,
multidimensional approach that should transform how we view lung regeneration and fibrogenesis and how we
treat patients with unrelenting fibrosis.
摘要
这项研究的目标是了解肺上皮和间充质之间的相互作用。
足够详细的细胞来提供新的肺纤维化治疗干预措施,这是一个没有疾病的过程
修改治疗方法。该程序由最近资助的RO1支持,以进一步阐明
成纤维细胞特异性的三羟基酚抑制剂LOXL2和TGFR1在体内具有强大的抗纤维化作用。我们
将在一项原则证明临床试验中测试其中一种EGCG。未公布的数据显示核心集合的反转
在诊断肺活检前两周服用EGCG的IPF患者中促纤维化组织生物标志物的变化。这个
R35机制使我们能够将我们减轻纤维化的能力与更广泛的缺陷问题结合起来
IPF中的上皮再生是与纤维化形成竞争的过程。这有时在思想上被简化了
反复的上皮损伤会导致干细胞衰竭,从而创造一个无情的促纤维化环境。但
肺具有弹性,有多个在空间上不同的祖细胞,它们具有识别和整合功能。
仍然知之甚少,尤其是在IPF患者中。这种范式也忽略了潜在的关键
促纤维化间充质细胞在推动上皮进一步丧失中的作用。IPF中的II型细胞
肺移植时的肺活量不到正常肺的15%。该计划将重点放在
关于进一步阐明小鼠和人体内常驻上皮干/祖细胞再生潜力的研究
牙槽骨完整。同时,激活的间充质细胞促进功能障碍和
这些上皮祖细胞的丧失将被定义。我们计划利用成纤维细胞特异性的TGFb1抑制来
在两种动物模型和IPF患者中研究其对祖细胞的影响,例如通过单细胞RNA-
对未经治疗和EGCG治疗的患者的组织进行SEQ。我们展望了未来基于图像的小分子
筛选出在培养的上皮/成纤维细胞类器官中改善II型细胞健康的药物。总体而言
R35计划让我们有机会将所有这些方向整合到一个中心主题中,
多维方法应该改变我们看待肺再生和纤维化的方式以及我们如何
治疗患有顽固性纤维化的患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harold A Chapman其他文献
Harold A Chapman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harold A Chapman', 18)}}的其他基金
Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
IPF 患者口服表没食子儿茶素-3-没食子酸酯 (EGCG) 的 1 期研究
- 批准号:
10702133 - 财政年份:2022
- 资助金额:
$ 96.55万 - 项目类别:
Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
IPF 患者口服表没食子儿茶素-3-没食子酸酯 (EGCG) 的 1 期研究
- 批准号:
10418169 - 财政年份:2022
- 资助金额:
$ 96.55万 - 项目类别:
Program to promote lung regeneration and block fibrosis
促进肺再生和阻止纤维化的计划
- 批准号:
10570862 - 财政年份:2020
- 资助金额:
$ 96.55万 - 项目类别:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
上皮干/祖细胞作为弥漫性肺泡损伤的修复剂
- 批准号:
10181019 - 财政年份:2016
- 资助金额:
$ 96.55万 - 项目类别:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
上皮干/祖细胞作为弥漫性肺泡损伤的修复剂
- 批准号:
9355470 - 财政年份:2016
- 资助金额:
$ 96.55万 - 项目类别:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
上皮干/祖细胞作为弥漫性肺泡损伤的修复剂
- 批准号:
10418711 - 财政年份:2016
- 资助金额:
$ 96.55万 - 项目类别:
Epithelial Stem/Progenitor Cells in Repair of the Injured Lung
上皮干细胞/祖细胞修复受损肺
- 批准号:
9109038 - 财政年份:2015
- 资助金额:
$ 96.55万 - 项目类别:
Identification, Isolation, and Reprogramming Alveolar Epithelial Progenitor Cells
肺泡上皮祖细胞的鉴定、分离和重编程
- 批准号:
7676645 - 财政年份:2008
- 资助金额:
$ 96.55万 - 项目类别:
Urokinase Receptor Integrin Interactions in Lung Cancer
肺癌中尿激酶受体整合素相互作用
- 批准号:
7318124 - 财政年份:2007
- 资助金额:
$ 96.55万 - 项目类别:
Urokinase Receptor Integrin Interactions in Lung Cancer
肺癌中尿激酶受体整合素相互作用
- 批准号:
8079454 - 财政年份:2007
- 资助金额:
$ 96.55万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 96.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists